These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2031393

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
    Heidrich H, Brodel C, Meuche C, Hellmann G, Ranft J.
    Vasa Suppl; 1989; 27():46. PubMed ID: 2623542
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
    Creutzig A, Caspary L, Alexander K.
    Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial.
    Mlekusch W, Schillinger M, Sabeti S, Al-Awami M, Gschwandtner M, Minar E.
    Vasa; 2004 Aug; 33(3):131-6. PubMed ID: 15461064
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J, Caspary L, Creutzig A, Alexander K.
    Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapeutic efficacy of intravenously applied prostaglandin E1.
    Scheffler P, de la Hamette D, Leipnitz G.
    Vasa Suppl; 1989 May; 28():19-25. PubMed ID: 2609240
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A, Arnold A, Caspary L, Thum J, Alexander K.
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.